Table 1 Allele frequencies of the markers investigated in the different study populations (AFR, AMR, EAS, EUR, SAS, and NAT).

From: Characterization of pharmacogenetic markers related to Acute Lymphoblastic Leukemia toxicity in Amazonian native Americans population

Gene

SNP, ID

Reference allele

Frequency in population:

NAT

AFR

AMR

EAS

EUR

SAS

TPMT

rs1142345

T

0.873

0.933

0.942

0.978

0.971

0.982

TPMT

rs1800460

C

0.946

0.997

0.959

1

0.972

0.995

MTHFR

rs1801133

G

0.712

0.909

0.525

0.704

0.635

0.881

MTRR

rs1801394

A

0.903

0.754

0.719

0.737

0.477

0.475

MTHFD1

rs2236225

G

0.174

0.842

0.455

0.801

0.570

0.495

GGH

rs1800909

A

0.883

0.833

0.772

0.780

0.720

0.713

GGH

rs3758149

G

0.581

0.833

0.772

0.780

0.721

0.713

ATIC

rs4673993

T

0.323

0.905

0.693

0.706

0.686

0.509

ATIC

rs2372536

C

0.336

0.934

0.691

0.707

0.683

0.507

SLCO1B1

rs2306283

A

0.290

0.182

0.527

0.238

0.597

0.452

SLCO1B1

rs4149056

T

0.548

0.986

0.865

0.876

0.838

0.957

CCND1

rs9344

G

0.735

0.812

0.651

0.428

0.502

0.483